1. Home
  2. USEG vs SCYX Comparison

USEG vs SCYX Comparison

Compare USEG & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USEG
  • SCYX
  • Stock Information
  • Founded
  • USEG 1966
  • SCYX 1999
  • Country
  • USEG United States
  • SCYX United States
  • Employees
  • USEG N/A
  • SCYX N/A
  • Industry
  • USEG Oil & Gas Production
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • USEG Energy
  • SCYX Health Care
  • Exchange
  • USEG Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • USEG 42.2M
  • SCYX 36.8M
  • IPO Year
  • USEG N/A
  • SCYX 2014
  • Fundamental
  • Price
  • USEG $1.31
  • SCYX $0.88
  • Analyst Decision
  • USEG Strong Buy
  • SCYX
  • Analyst Count
  • USEG 2
  • SCYX 0
  • Target Price
  • USEG $2.75
  • SCYX N/A
  • AVG Volume (30 Days)
  • USEG 277.4K
  • SCYX 200.1K
  • Earning Date
  • USEG 05-12-2025
  • SCYX 05-15-2025
  • Dividend Yield
  • USEG N/A
  • SCYX N/A
  • EPS Growth
  • USEG N/A
  • SCYX N/A
  • EPS
  • USEG N/A
  • SCYX N/A
  • Revenue
  • USEG $16,340,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • USEG $23.82
  • SCYX $460.12
  • Revenue Next Year
  • USEG N/A
  • SCYX $253.87
  • P/E Ratio
  • USEG N/A
  • SCYX N/A
  • Revenue Growth
  • USEG N/A
  • SCYX N/A
  • 52 Week Low
  • USEG $0.81
  • SCYX $0.72
  • 52 Week High
  • USEG $6.40
  • SCYX $2.60
  • Technical
  • Relative Strength Index (RSI)
  • USEG 55.26
  • SCYX 49.39
  • Support Level
  • USEG $1.22
  • SCYX $0.85
  • Resistance Level
  • USEG $1.37
  • SCYX $1.02
  • Average True Range (ATR)
  • USEG 0.09
  • SCYX 0.08
  • MACD
  • USEG 0.01
  • SCYX 0.01
  • Stochastic Oscillator
  • USEG 53.03
  • SCYX 54.60

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: